Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Cyterix Pharmaceuticals
AddedFeb 15, 2024
UpdatedJun 18, 2026
Cyterix Pharmaceuticals

Cyterix Pharmaceuticals

Acquired

Cyterix Pharmaceuticals develops targeted cancer therapeutic drugs, serving the global medical community.

HQ
San Francisco, CA, US
Founded
2010
Overview
Compare
Fundraising
Employees

Cyterix Pharmaceuticals develops targeted cancer therapeutic drugs, specializing in combining enzymes to specifically target cancer cells. The company serves the global medical community, focusing on innovative treatments to improve cancer care.

Cyterix Pharmaceuticals has made significant strides in the field of oncology, contributing to advancements in targeted cancer therapies. Their innovative approach has garnered attention and support from the international medical community, enhancing their impact on cancer treatment.

Cyterix Pharmaceuticals - Similar Companies

CytomX Therapeutics logo

CytomX Therapeutics

cytomx.com

Oncolix logo

Oncolix

Altiris Therapeutics logo

Altiris Therapeutics

Novita Pharmaceuticals logo

Novita Pharmaceuticals

novita-pharm.com

Citius Pharmaceuticals logo

Citius Pharmaceuticals

citiuspharma.com

Nerx Biosciences logo

Nerx Biosciences

Palm Therapeutics logo

Palm Therapeutics

XTuit Pharmaceuticals logo

XTuit Pharmaceuticals

OmniCyte logo

OmniCyte

omnicyte.com

Cellix Bio logo

Cellix Bio

Clovis Oncology logo

Clovis Oncology

Tigris Pharmaceuticals logo

Tigris Pharmaceuticals

tigrispharma.com

BioNumerik Pharmaceuticals logo

BioNumerik Pharmaceuticals

Camino Pharma logo

Camino Pharma

caminopharma.com

CerRx logo

CerRx

cerrx.com

Cyterix Pharmaceuticals - Quick Facts

Who are Cyterix Pharmaceuticals' competitors?

Companies similar to Cyterix Pharmaceuticals include CytomX Therapeutics, Oncolix, Altiris Therapeutics and Novita Pharmaceuticals.

When was Cyterix Pharmaceuticals founded?

Cyterix Pharmaceuticals was founded in 2010.

Where is Cyterix Pharmaceuticals' headquarters located?

Cyterix Pharmaceuticals' headquarters is located in San Francisco, CA, US.

When was Cyterix Pharmaceuticals' last funding round?

Cyterix Pharmaceuticals' most recent funding round was for $7.3M (USD) in July 2012.

How much has Cyterix Pharmaceuticals raised to-date?

As of Jul 1, 2012, Cyterix Pharmaceuticals has raised a total of $16.5M (USD).

Cyterix Pharmaceuticals - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Licensing
  • Recurring
  • Software
Customer
  • Enterprise
  • Government
Main Product
  • Cancer Drugs
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified